Pregnancy Outcomes in Congenital Myasthenie Syndrome

Institut de Myologie, France25 enrolled

Overview

This is a retrospective study that follows the clinical evolution, the pregnancy and the post-partum perioad of female patients with Congenital Myasthenic Syndrome.

The aim of this study is to better understand the action of hormonal factors that are presumably incriminated for the fluctuation of the disease. The investigators would also like to better adress the issues of women with Congenital Myasthenic Syndrome, who desire a pregnancy : the possibility of decompensation, the problems that can arise during the course of the childbearing, the risk of foetal malformations.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Congenital Myasthenic Syndrome

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion criteria: * Adult women * Congenital myastenic syndrome genetically confirmed or with clinical compatible and electrophysiological evidence * Written consent Exclusion Criteria: * Neurological or general pathology occurs significantly with the initiation and conduct of a pregnancy.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.